Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07252687

The Effect of Gender-affirmative Measures on Breast Perception in Trans Men

The Effect of Gender-affirmative Measures on Breast Perception in Trans Men (TRANSBREAST) - a Prospective Cohort Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Medical University Innsbruck · Academic / Other
Sex
Female
Age
16 Years
Healthy volunteers

Summary

Breast dysphoria in transmasculine or genderdiverse individuals is a distinct psychological burden associated with depression, anxiety and suicidality. The aim is to systematically investigate the effect of GAHT (gender-affirming hormone therapy) and mastectomy on this form of dysphoria. The primary objective of this study is to analyse and investigate the psychological and physical effects of breast development on trans men or genderdiverse individuals. A secondary objective is to determine the extent to which the stress affects the well-being of trans men depending on the coping strategies used (binding vs. taping).

Conditions

Interventions

TypeNameDescription
OTHERquality of life questionnaire- iTransQoL, chest dysphoria measureBefore starting treatment, participants should complete the Chest Dysphoria Measure and iTransQoL questionnaires (=time point 0). The second time point for completing the questionnaires again is 3 months after starting hormone therapy. Subsequently, the questionnaires should be completed a third time after breast-affirming surgery. The final survey takes place two years after time point 0, or 6 months after the previous survey.

Timeline

Start date
2025-11-30
Primary completion
2030-11-01
Completion
2030-11-01
First posted
2025-11-28
Last updated
2026-03-06

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT07252687. Inclusion in this directory is not an endorsement.